KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Minority Interest (2016 - 2025)

Historic Minority Interest for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $310.0 million.

  • Abbott Laboratories' Minority Interest rose 3362.07% to $310.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.0 million, marking a year-over-year increase of 3362.07%. This contributed to the annual value of $237.0 million for FY2024, which is 580.36% up from last year.
  • Per Abbott Laboratories' latest filing, its Minority Interest stood at $310.0 million for Q3 2025, which was up 3362.07% from $264.0 million recorded in Q2 2025.
  • Abbott Laboratories' Minority Interest's 5-year high stood at $310.0 million during Q3 2025, with a 5-year trough of $209.0 million in Q3 2022.
  • Over the past 5 years, Abbott Laboratories' median Minority Interest value was $229.0 million (recorded in 2021), while the average stood at $233.5 million.
  • Its Minority Interest has fluctuated over the past 5 years, first tumbled by 347.83% in 2023, then soared by 3362.07% in 2025.
  • Quarter analysis of 5 years shows Abbott Laboratories' Minority Interest stood at $222.0 million in 2021, then decreased by 1.35% to $219.0 million in 2022, then rose by 2.28% to $224.0 million in 2023, then rose by 5.8% to $237.0 million in 2024, then soared by 30.8% to $310.0 million in 2025.
  • Its last three reported values are $310.0 million in Q3 2025, $264.0 million for Q2 2025, and $253.0 million during Q1 2025.